Axiv Sinus Severe Ultra Fine Mist Aerosol, Spray
NDC Package 82706-030-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Axiv Sinus Severe Ultra Fine Mist (oxymetazoline hydrochloride.) aerosols is adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more than every 10 to 12 hours. This formulation utilizes a aerosol, spray delivery system. Marketed by Vivunt Pharma Llc, this product is identified by NDC 82706-030 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
82706-030-01
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 15 mL in 1 BOTTLE, SPRAY
Product Code
82706-030
11-Digit Billing Format
82706003001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Axiv Sinus Severe Ultra Fine Mist
Non-Proprietary Name
Oxymetazoline Hydrochloride.
Substance Name
Oxymetazoline Hydrochloride
Dosage Form
Aerosol, Spray - An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
OXYMETAZOLINE HYDROCHLORIDE .5 mg/mL
Pharmacologic Class
Usage Information
Adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.children under 6 years of age: ask a doctorTo Useremove protective capbefore using for the first time, prime the pump by firmly depressing its rim several timeshold container with thumb at base and nozzle between first and second fingerswithout tilting your head, inset nozzle into nostrilfully depress rim with a firm, even stroke and inhale deeply.How to use:Hold white tabs; SQUEEZE grooved area of cap FIRMLY and turn counter clockwise. Secure cap after use.

Regulatory & Marketing

Labeler Name
Vivunt Pharma Llc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-19-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82706-030-01 identifies a specific commercial package of 1 bottle, spray in 1 carton / 15 ml in 1 bottle, spray of Axiv Sinus Severe Ultra Fine Mist, a human over the counter drug labeled by Vivunt Pharma Llc. This aerosol, spray is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vivunt Pharma Llc on January 19, 2026. The current certification is valid through December 31, 2027.

How is this Vivunt Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82706003001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82706-030-01
11-Digit CMS (5-4-2)
82706-0030-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.